Tolonen Ari, Pelkonen Olavi
Admescope Ltd, Typpitie 1, FIN-90620 Oulu, Finland.
University of Oulu, Department of Pharmacology and Toxicology, Aapistie 5 B (POB 5000), FIN-90014 Oulu, Finland.
Toxicology. 2015 Jun 5;332:20-9. doi: 10.1016/j.tox.2013.08.010. Epub 2013 Aug 28.
For quantitative in vitro-in vivo extrapolation (QIVIVE) of metabolism for the purposes of toxicokinetics prediction, a precise and robust analytical technique for identifying and measuring a chemical and its metabolites is an absolute prerequisite. Currently, high-resolution mass spectrometry (HR-MS) is a tool of choice for a majority of organic relatively lipophilic molecules, linked with a LC separation tool and simultaneous UV-detection. However, additional techniques such as gas chromatography, radiometric measurements and NMR, are required to cover the whole spectrum of chemical structures. To accumulate enough reliable and robust data for the validation of QIVIVE, there are some partially opposing needs: Detailed delineation of the in vitro test system to produce a reliable toxicokinetic measure for a studied chemical, and a throughput capacity of the in vitro set-up and the analytical tool as high as possible. We discuss current analytical challenges for the identification and quantification of chemicals and their metabolites, both stable and reactive, focusing especially on LC-MS techniques, but simultaneously attempting to pinpoint factors associated with sample preparation, testing conditions and strengths and weaknesses of a particular technique available for a particular task.
为了进行毒代动力学预测而对代谢进行定量体外-体内外推(QIVIVE),一种用于识别和测量化学物质及其代谢物的精确且可靠的分析技术是绝对必要的前提条件。目前,高分辨率质谱(HR-MS)是大多数相对亲脂性有机分子的首选工具,它与液相色谱分离工具及同步紫外检测联用。然而,还需要诸如气相色谱、放射性测量和核磁共振等其他技术来涵盖整个化学结构谱。为了积累足够可靠且稳健的数据以验证QIVIVE,存在一些部分相互矛盾的需求:详细描述体外测试系统,以便为所研究的化学物质产生可靠的毒代动力学测量值,以及体外设置和分析工具尽可能高的通量能力。我们讨论了当前在识别和定量化学物质及其代谢物(包括稳定的和反应性的)方面的分析挑战,特别关注液相色谱-质谱技术,但同时试图找出与样品制备、测试条件以及适用于特定任务的特定技术的优缺点相关的因素。